Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading ->
The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading ->
Global health reaped a weekend windfall of new international and bilateral commitments over the past two days, beginning with the close of the G20 meeting in Argentina on Saturday, followed by the Mandela 100 Global Citizen festival in Johannesburg yesterday, which saw stars like Beyoncé, Jay-Z and others perform in the name of health and development causes, reaping a historic commitment by the United States of more than US$1.2 billion for the fight against HIV/AIDS and some US$ 139 million for the fight against neglected tropical diseases. Continue reading ->
A report launched jointly today by Population Services International (PSI), London School of Hygiene and Tropical Medicine and the World Health Organization shows that people’s knowledge of their HIV status in sub-Saharan African countries nearly doubled just four years after self-testing programmes were introduced. Separately, a group of French NGOs called on the French President to lead elimination of HIV/AIDS, tuberculosis and malaria by 2030. Continue reading ->
A global index on access to medicine has found that the majority of the medicines needed by the world’s poor are developed by only five companies, and that these medicines are focused primarily on just five diseases. The group behind the index calls on more pharmaceutical companies to join efforts for increased access and to expand the list of medicines, in order to build resilience in treating diseases that affect the poor. Continue reading ->
A World Health Organization report released today has found that global malaria cases are around the same level as last year, confirming that progress to address the disease has stalled. Rates of malaria are up in high-burden countries, while rates have decreased in other countries due to country-led efforts, the report found. To bring progress back on track to meet global targets, the WHO and partners today announced a new response led by high-burden countries to scale up malaria prevention and treatment. Continue reading ->
WASHINGTON, DC -- The United States is one of the biggest funders of reproductive health and family planning in multiple developing countries. It is also one of the biggest distributors of contraceptive services in the international market providing all but one: Abortion. The US congressional midterm elections taking place on 6 November could influence further proposed changes to these policies by the current US administration, potentially affecting the lives of millions of women worldwide, for better or worse. Continue reading ->